Cargando…

Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance

Background: Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured by a persistent state of insulin resistance (IR), which increases the release of free fatty acids from abdominal adi...

Descripción completa

Detalles Bibliográficos
Autores principales: Paublini, Hernán, López González, Angel Arturo, Busquets-Cortés, Carla, Tomas-Gil, Pilar, Riutord-Sbert, Pere, Ramírez-Manent, José Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180556/
https://www.ncbi.nlm.nih.gov/pubmed/37432258
http://dx.doi.org/10.3390/nu15092105
_version_ 1785041362892095488
author Paublini, Hernán
López González, Angel Arturo
Busquets-Cortés, Carla
Tomas-Gil, Pilar
Riutord-Sbert, Pere
Ramírez-Manent, José Ignacio
author_facet Paublini, Hernán
López González, Angel Arturo
Busquets-Cortés, Carla
Tomas-Gil, Pilar
Riutord-Sbert, Pere
Ramírez-Manent, José Ignacio
author_sort Paublini, Hernán
collection PubMed
description Background: Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured by a persistent state of insulin resistance (IR), which increases the release of free fatty acids from abdominal adipose tissue. This alteration in the lipid profile favours the accelerated development of atherosclerosis, which is the most important cause of morbidity and mortality in all countries in the developed and developing world. One of the elements that plays a major role in the genesis of AD is IR. The aim of this study was to determine the relationship between variables that assess atherogenic risk (AD and LT) and scales that assess the risk of presenting insulin resistance. Methods: A descriptive cross-sectional study of 418,343 workers was conducted to evaluate atherogenic dyslipidaemia and lipid triad; a relationship with three insulin resistance risk scales (Triglycerides/HDL, TyG index, METS-IR) was established. The usefulness of IR risk scales for predicting AD and LT was calculated by applying ROC curves, obtaining the area under the curve (AUC) and cut-off points with their sensitivity, specificity, and Youden index. Multivariate analysis was performed by binary logistic regression. Results: The prevalence of high-risk values for insulin resistance with all of the scales is much higher in people with AD and LT compared to those without. The ROC curves present us with an AUC with the three insulin resistance risk scales for the two dyslipidaemias studied with figures ranging between 0.856 and 0.991, which implies that the results are good/very good. Conclusions: A relationship between atherogenic dyslipidaemia and the three insulin resistance risk scales assessed is revealed, with higher IR mean values and prevalence in people with atherogenic dyslipidaemia and lipid triad. The three scales make it possible to adequately classify the presence of AD and LT. The highest AUC is presented by the triglycerides/HDL scale, with a result close to 1. METS-IR is the most recommended formula to estimate insulin resistance.
format Online
Article
Text
id pubmed-10180556
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101805562023-05-13 Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance Paublini, Hernán López González, Angel Arturo Busquets-Cortés, Carla Tomas-Gil, Pilar Riutord-Sbert, Pere Ramírez-Manent, José Ignacio Nutrients Article Background: Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured by a persistent state of insulin resistance (IR), which increases the release of free fatty acids from abdominal adipose tissue. This alteration in the lipid profile favours the accelerated development of atherosclerosis, which is the most important cause of morbidity and mortality in all countries in the developed and developing world. One of the elements that plays a major role in the genesis of AD is IR. The aim of this study was to determine the relationship between variables that assess atherogenic risk (AD and LT) and scales that assess the risk of presenting insulin resistance. Methods: A descriptive cross-sectional study of 418,343 workers was conducted to evaluate atherogenic dyslipidaemia and lipid triad; a relationship with three insulin resistance risk scales (Triglycerides/HDL, TyG index, METS-IR) was established. The usefulness of IR risk scales for predicting AD and LT was calculated by applying ROC curves, obtaining the area under the curve (AUC) and cut-off points with their sensitivity, specificity, and Youden index. Multivariate analysis was performed by binary logistic regression. Results: The prevalence of high-risk values for insulin resistance with all of the scales is much higher in people with AD and LT compared to those without. The ROC curves present us with an AUC with the three insulin resistance risk scales for the two dyslipidaemias studied with figures ranging between 0.856 and 0.991, which implies that the results are good/very good. Conclusions: A relationship between atherogenic dyslipidaemia and the three insulin resistance risk scales assessed is revealed, with higher IR mean values and prevalence in people with atherogenic dyslipidaemia and lipid triad. The three scales make it possible to adequately classify the presence of AD and LT. The highest AUC is presented by the triglycerides/HDL scale, with a result close to 1. METS-IR is the most recommended formula to estimate insulin resistance. MDPI 2023-04-27 /pmc/articles/PMC10180556/ /pubmed/37432258 http://dx.doi.org/10.3390/nu15092105 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Paublini, Hernán
López González, Angel Arturo
Busquets-Cortés, Carla
Tomas-Gil, Pilar
Riutord-Sbert, Pere
Ramírez-Manent, José Ignacio
Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
title Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
title_full Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
title_fullStr Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
title_full_unstemmed Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
title_short Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
title_sort relationship between atherogenic dyslipidaemia and lipid triad and scales that assess insulin resistance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180556/
https://www.ncbi.nlm.nih.gov/pubmed/37432258
http://dx.doi.org/10.3390/nu15092105
work_keys_str_mv AT paublinihernan relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance
AT lopezgonzalezangelarturo relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance
AT busquetscortescarla relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance
AT tomasgilpilar relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance
AT riutordsbertpere relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance
AT ramirezmanentjoseignacio relationshipbetweenatherogenicdyslipidaemiaandlipidtriadandscalesthatassessinsulinresistance